UbiVac
Home Collaboration Contact
New Index
Overview Executive Leadership Board of Directors Advisory Board
Technologies Pipeline
Presentations Publications Press Releases In the News
Home About Overview Executive Leadership Board of Directors Advisory Board Research & Pipeline Technologies Pipeline Collaboration Newsroom Presentations Publications Press Releases In the News Contact
UbiVac
New Index
UbiVac Announces Preliminary Immunological Data from 1st-In-Human Trial of DPV-001 Immunotherapy Trio for Advanced HNSCC
Bernie FoxFebruary 1, 2024
Facebook0 Twitter 0 Likes
Previous

Bernie FoxApril 3, 2024
Next

FDA Grants Approval for UbiVac Manufactured Coronavirus Vaccine to Start Clinical Trial

Bernie FoxOctober 29, 2020

© 2020 UbiVac | All rights reserved.